InVivo Therapeutics Receives Massachusetts Life Sciences Center Accelerator Program Award

CAMBRIDGE, Mass.--(Business Wire)--
Medical device company InVivo Therapeutics Corporation received an award of
$500,000 from the Massachusetts Life Sciences Center today as part of MLSC`s
Accelerator Program.

The Accelerator Program, designed to provide support to early-stage life
sciences companies that demonstrate a strong potential for commercialization and
growth, is one facet of the state`s $1 billion Massachusetts Life Sciences Act.
InVivo Therapeutics was selected as an award recipient after a competitive
application process that included both peer review and a presentation before the
MLSC Scientific Advisory Board.

According to MLSC President and CEO Dr. Susan Windham-Bannister: "We have great
confidence in your outstanding team and technology, and in your ability to
benefit humanity while creating jobs for the commonwealth of Massachusetts."

The award was approved this afternoon during a session of the MLSC Board of
Directors. Frank Reynolds, President and CEO of InVivo Therapeutics, made an
appearance with Dr. Windham-Bannister on New England Cable News New England
Business Day in the evening.

Reynolds calls the award an honor and a "real validation of all the hard work
InVivo has completed as a team."

"We are thrilled to be recognized by the MLSC. It is this kind of support and
dedication to the life sciences community that excites companies like InVivo to
remain in Massachusetts, and enables us to thrive here," says Reynolds.

InVivo Therapeutics plans to put the funds toward advancing their technology to
market. InVivo is currently in the midst of a second round of non-human primate
studies and is looking towards clinical trials.

InVivo Therapeutics Corporation is a Cambridge, MA medical device company
focused on combining polymers and stem cells to restore function in individuals
paralyzed as a result of traumatic spinal cord injury. The company was founded
in 2005 on the basis of research initiated in the laboratories of Robert Langer,
PhD, of the Massachusetts Institute of Technology, and Jay Vacanti, MD, of the
Massachusetts General and Children`s Hospitals in Boston.

InVivo Therapeutics
Frank Reynolds, 617-475-1518
Public Relations
publicrelations@invivotherapeutics.com

Copyright Business Wire 2009